Skip to main content
. Author manuscript; available in PMC: 2020 Aug 28.
Published in final edited form as: Endocrinol Metab Clin North Am. 2020 Mar;49(1):79–93. doi: 10.1016/j.ecl.2019.11.002

Table 2.

Non-ICU CGM studies

Authors CGM Type Patient Population Study Design Outcomes Results
Burt et al,15 2013 CGMS Gold (Medtronic MiniMed) T1DM and T2DM admitted to general wards on basal bolus insulin (n = 26) Observational Prospective Cohort: blinded CGM vs POC glucose testing Accuracy and glycemic control No significant difference in glycemic control; most hyperglycemic episodes were postprandial and hypoglycemic episodes more likely to occur between midnight and 7 AM
Schaupp et al,16 2015 iPro2 system (Medtronic MiniMed) T2DM admitted to general wards on basal bolus insulin (n = 84) Observational Prospective Cohort: blinded CGM vs POC glucose testing Accuracy Good agreement between CGM and POC glucose values; Clarke Error Grid analysis with 98.7% of values in Zone A or Zone B (88.2% within Zone A); 15-fold increase in detection of nocturnal hypoglycemia with CGM.
Gómez et al,17 2015 iPro2 system (Medtronic MiniMed) T2DM or hyperglycemia admitted to general wards on basal bolus insulin (n = 38) Prospective Pilot RCT: blinded CGM vs POC glucose testing Accuracy Good agreement between CGM and POC glucose values; Clarke Error Grid analysis with 91.9% of values in Zone A or Zone B. Increased detection of hypoglycemic episodes with CGM (55 vs 12, P<.01).
Gu et al,18 2017 Paradigm 722 or CGMS Gold (Medtronic MiniMed) T2DM admitted to general wards for glycemic control (n = 81) Prospective RCT: SAP vs MDI with blinded CGM Glycemic control, time to target glucose 21 SAP vs 6 MDI patients achieved glycemic targets within 3 d. SAP vs MDI had less hypoglycemia (sensor glucose <50 mg/dL: 0.04% vs 0.32%; P<.05) and hyperglycemia (sensor glucose >180 mg/dL: 21.56% vs 35.03%; P<.05).
Spanakis et al,19 2018 DEXCOM G4 CGM with Share2 application (DEXCOM) T2DM admitted to general wards on insulin therapy (n = 5) Single-arm pilot trial of consecutive patients using glucose telemetry system (CGM alert at 85 mg/dL) Glucose telemetry system feasibility Prevention of potential hypoglycemia (CGM BG <70 mg/dL for >20 min) captured by alarm occurred in 2 patients (3 events). No patients had CGM glucose value <54 mg/dL.

Conversion: mg/dL × 0.0555 = mmol/L.

Abbreviations: BG, blood glucose; CGM, continuous glucose monitoring; CGMS, continuous glucose monitoring system; ICU, intensive care unit; MDI, multiple daily injections; POC, point of care; SAP, sensor-augmented pump; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus;

Data from Refs.1519